Itiquira Acquisition Corp. was established as a special purpose acquisition company, intending to execute a merger, share exchange, asset acquisition, or similar business combination with an operating entity. The firm sought opportunities primarily within Brazil, targeting sectors such as technology, healthcare, pharmaceuticals, education, and consumer services, characterized by strong growth potential and resilient business models. Founded in 2020 and based in New York, New York, the company subsequently announced its decision in February 2023 to liquidate and redeem its public shares, having not completed an initial business combination within the mandated timeframe.